Markus Galler,Christoph Chibolela,Felix Thiele,Julian Manuel Michael Rogasch,Holger Amthauer
{"title":"Dose-rate effects and tumor control probability in177Lu-based targeted radionuclide therapy: a theoretical analysis.","authors":"Markus Galler,Christoph Chibolela,Felix Thiele,Julian Manuel Michael Rogasch,Holger Amthauer","doi":"10.1088/1361-6560/ad7cbe","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\n177Lu-based targeted radionuclide therapy (TRT) has become an important cancer treatment option in recent years, in particular in the treatment of advanced prostate cancer and metastasized neuroendocrine tumors. Although it is known from conventional radiotherapy that the temporal dynamics of the dose-rate can be of relevance for tumor cell survival, the analysis of TRT efficacy usually considers only the absorbed dose. Thus, the aim of this theoretical analysis is to shed light on the possible effects of the pattern of dose-rate in TRT on tumor control probability (TCP).\r\n\r\nAPPROACH\r\nFor this purpose, TCP is studied numerically in a typical four-cycle treatment regime based on the mechanistic lethal-potentially lethal model and the Zaider-Minerbo model for TCP including repopulation of tumor cells.\r\n\r\nMAIN RESULTS\r\nIt is shown that the dose-rate pattern in TRT can have a substantial effect on TCP even though the absorbed dose in the tumor lesion is unchanged. These dose-rate effects are particularly evident when repair of potentially lethal lesions is slow.\r\n\r\nSIGNIFICANCE\r\nThe results indicate that in some situations in the analysis of the efficacy of TRT it is necessary to consider the full dose-rate pattern instead of the absorbed dose alone. This can be highly relevant for optimization and further development of TRTs. In particular, it could be of relevancy in studying the efficacy of newly emerging treatment concepts that combine the use of TRT and drugs that inhibit DNA damage repair.","PeriodicalId":519254,"journal":{"name":"Physics in Medicine & Biology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physics in Medicine & Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1088/1361-6560/ad7cbe","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVE
177Lu-based targeted radionuclide therapy (TRT) has become an important cancer treatment option in recent years, in particular in the treatment of advanced prostate cancer and metastasized neuroendocrine tumors. Although it is known from conventional radiotherapy that the temporal dynamics of the dose-rate can be of relevance for tumor cell survival, the analysis of TRT efficacy usually considers only the absorbed dose. Thus, the aim of this theoretical analysis is to shed light on the possible effects of the pattern of dose-rate in TRT on tumor control probability (TCP).
APPROACH
For this purpose, TCP is studied numerically in a typical four-cycle treatment regime based on the mechanistic lethal-potentially lethal model and the Zaider-Minerbo model for TCP including repopulation of tumor cells.
MAIN RESULTS
It is shown that the dose-rate pattern in TRT can have a substantial effect on TCP even though the absorbed dose in the tumor lesion is unchanged. These dose-rate effects are particularly evident when repair of potentially lethal lesions is slow.
SIGNIFICANCE
The results indicate that in some situations in the analysis of the efficacy of TRT it is necessary to consider the full dose-rate pattern instead of the absorbed dose alone. This can be highly relevant for optimization and further development of TRTs. In particular, it could be of relevancy in studying the efficacy of newly emerging treatment concepts that combine the use of TRT and drugs that inhibit DNA damage repair.
目的177Lu放射性核素靶向治疗(TRT)近年来已成为一种重要的癌症治疗方法,尤其是在治疗晚期前列腺癌和转移性神经内分泌肿瘤方面。虽然从传统放疗中可以看出,剂量率的时间动态与肿瘤细胞的存活有关,但对 TRT 疗效的分析通常只考虑吸收剂量。因此,本理论分析的目的是揭示 TRT 中剂量率模式对肿瘤控制概率(TCP)可能产生的影响。方法为此目的,我们在一个典型的四周期治疗机制中对 TCP 进行了数值研究,该机制基于致死-潜在致死模型和 Zaider-Minerbo 模型,TCP 包括肿瘤细胞的再增殖。主要结果表明,即使肿瘤病灶的吸收剂量不变,TRT 中的剂量率模式也会对 TCP 产生重大影响。结果表明,在分析 TRT 疗效的某些情况下,有必要考虑全部剂量率模式,而不是仅考虑吸收剂量。这可能与 TRT 的优化和进一步开发密切相关。特别是在研究结合使用TRT和抑制DNA损伤修复药物的新兴治疗概念的疗效时,这一点可能具有重要意义。